Taiguang Jin

Head of Discovery Biology

BrightPath Biotherapeutics
Country flagUnited States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Taiguang Jin is the Head of Discovery Biology at Bridge Biotherapeutics, Inc. in the United States. His research primarily focuses on targeted therapies for cancer treatment, with recent investigations into fourth-generation tyrosine kinase inhibitors for osimertinib-resistant EGFR mutations in non-small cell lung cancer. Dr. Jin's work aims to advance effective treatment options for challenging cancer mutations.

Articles (1)

Year:

2023

Collaborators (2)

Gwanghee Lee

-

SOUTH KOREA
View details

Dong-Wan Kim

Associate Professor

Seoul National University Hospital

SOUTH KOREA
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.